Phase II evaluation of spirogermanium in advanced ovarian carcinoma

Cancer Treat Rep. 1983 Feb;67(2):193-4.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Drug Evaluation
  • Female
  • Germanium / administration & dosage
  • Germanium / therapeutic use*
  • Humans
  • Middle Aged
  • Organometallic Compounds*
  • Ovarian Neoplasms / drug therapy*
  • Spiro Compounds / administration & dosage
  • Spiro Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Organometallic Compounds
  • Spiro Compounds
  • Germanium
  • spirogermanium